Grissinger Michael has filed 6 insider transactions across 3 companies since June 2024.
Most recent transaction: a grant/award of 1045 shares of Aprea Therapeutics, Inc. ($APRE) on June 05, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2025 | Aprea Therapeutics, Inc. | $APRE | Grissinger Michael | Director | A | Common Stock | 1045 | $0.00 | 2,889.0000 | 5,993,866 | 56.67% | 0.02% |
| June 5, 2025 | Aprea Therapeutics, Inc. | $APRE | Grissinger Michael | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 5,993,866 | 9999.99% | 0.07% |
| April 17, 2025 | Adicet Bio, Inc. | $ACET | Grissinger Michael | Not found | A | Stock Option (Right to Buy) | 70200 | $0.00 | 70,200.0000 | 82,685,750 | 9999.99% | 0.08% |
| June 28, 2024 | Akari Therapeutics Plc | $AKTX | Grissinger Michael | Not found | A | Stock Option (Right to Buy) | 5000000 | $0.00 | 5,000,000.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Aprea Therapeutics, Inc. | $APRE | Grissinger Michael | Director | A | Common Stock | 1045 | $0.00 | 1,844.0000 | 4,198,326 | 130.79% | 0.02% |
| June 20, 2024 | Aprea Therapeutics, Inc. | $APRE | Grissinger Michael | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 4,198,326 | 9999.99% | 0.10% |